A17G (p.Ala17Gly) variant of EGFR (Epidermal growth factor receptor)
A17G (p.Ala17Gly) in EGFR (Epidermal growth factor receptor) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.23 / 1. The record also includes population frequency data and structural context.
A17G (p.Ala17Gly) variant details
- p.Ala17Gly
- TOPMed rs1180577495
- gnomAD rs1180577495
- Missense
- Variant Prioritization Score for Impact Estimate 0.225
- REVEL 0.13
- MetaLR 0.29
- MetaSVM -0.87
- CADD 12.60
- PolyPhen-2 0.00
- SIFT 1.00
- Population evidence available
- Structural context available